INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,574,792 | +3178.9% | 389,074 | +5157.8% | 0.03% | +3000.0% |
| Q3 2022 | $414,000 | -21.0% | 7,400 | -26.9% | 0.00% | 0.0% |
| Q2 2022 | $524,000 | -93.2% | 10,124 | -90.5% | 0.00% | -93.3% |
| Q1 2022 | $7,726,000 | -36.2% | 106,316 | +42.2% | 0.02% | -72.7% |
| Q2 2021 | $12,101,000 | +910.9% | 74,744 | +401.3% | 0.06% | +1000.0% |
| Q1 2021 | $1,197,000 | +63.3% | 14,909 | +10.7% | 0.01% | +25.0% |
| Q4 2020 | $733,000 | +200.4% | 13,466 | +18.0% | 0.00% | +100.0% |
| Q2 2016 | $244,000 | – | 11,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |